331 articles on this topic

  1. A man sits on a mat in a bright studio with a glass of water

    Zenagamtide: Amycretin’s New Name, Still in Trials

    Zenagamtide is amycretin’s new name: an experimental drug being tested as a weekly shot and a daily pill. Here’s what the trials actually found.

    October 11, 2026 · Nadia Okonjo, Health Writer

  2. A ball of undyed wool yarn on plain linen, a close view

    Tirzepatide and Thyroid: Levothyroxine Checks

    An underactive thyroid doesn't automatically rule out tirzepatide. Weight loss and changes in tablet absorption can make a thyroid-dose review worthwhile.

    October 10, 2026 · Priya Raman, Health Writer

  3. Two friends sit together on a window seat holding a pot of seedlings

    OASIS 4 Trial Results: 13.6% Weight Loss Explained

    The daily 25 mg tablet averaged 13.6% weight loss versus 2.2% with placebo at 64 weeks. The 16.6% headline assumes continued treatment.

    October 9, 2026 · Priya Raman, Health Writer

  4. A man sits on a blanket in a meadow beside a basket of apples

    Does Semaglutide Cause Thyroid Cancer?

    Human studies have not established that semaglutide causes thyroid cancer. The warning comes from tumors in rats and mice, and specific cancer histories rule out use.

    October 9, 2026 · Priya Raman, Health Writer

  5. A man sits on a bench between sets in a quiet gym with a folded towel

    What Does A1C Reduction Mean? A One-Point Drop

    A one-point A1C drop means about 29 mg/dL less estimated average blood sugar. Its meaning depends on the starting number and how safely it falls.

    October 9, 2026 · Elena Marsh, Health Writer

  6. Two ripe pears in a plain wooden bowl, a close view

    What Is Bioequivalence? What Generics Must Match

    Bioequivalence compares how two medicines reach the body. The 80–125% rule measures study uncertainty, and compounded drugs follow a different route.

    October 8, 2026 · Julian Reyes, Health Writer

  7. Two friends sit together on a bench in a utility room with a plain mug

    STEP UP Trial Results: 7.2 mg Versus 2.4 mg

    STEP UP compared two semaglutide doses with placebo over 72 weeks. The higher dose brought more weight loss and more stomach and skin symptoms.

    October 7, 2026 · Julian Reyes, Health Writer

  8. A man sits on a mat in a bright studio with a glass of water

    Tirzepatide and Pancreatitis: Risk and Symptoms

    Pancreatitis is uncommon in tirzepatide trials, but it remains a serious warning. Persistent or severe stomach pain needs urgent medical attention.

    October 7, 2026 · Julian Reyes, Health Writer

  9. A man sits on the bottom step of a staircase with a ball of yarn

    Semaglutide and Gallbladder: Risks and Symptoms

    Gallstones were more common in semaglutide trials, but most participants did not report them. Here are the Wegovy and Ozempic rates and the symptoms that need urgent care.

    October 6, 2026 · Priya Raman, Health Writer

  10. Three lemons on plain linen, a close view

    STEP-HFpEF Results: Symptoms, Weight and Limits

    Semaglutide improved symptoms and walking distance in two year-long trials of adults with obesity and heart failure. Here are the results, side effects and limits.

    October 6, 2026 · Priya Raman, Health Writer

  11. Two friends sit together on a driftwood log above a quiet beach

    SURPASS-CVOT Results: What the Heart Trial Found

    Tirzepatide met the trial’s standard for not being meaningfully worse than dulaglutide. It did not establish better heart outcomes.

    October 6, 2026 · Julian Reyes, Health Writer

  12. A woman stands beside a bicycle in a quiet lane holding an apple

    Open Enrollment GLP-1 Coverage: 2027 Checklist

    Coverage depends on the exact plan, product, and reason for prescribing. This fall's checklist covers dates, approval rules, refill costs, and Medicare's separate Bridge program.

    October 6, 2026 · Nadia Okonjo, Health Writer

  13. An empty bench in a quiet gym

    Semaglutide for PCOS: Weight Loss and Periods

    Semaglutide may help with weight loss in some people with PCOS. Evidence for more regular periods is growing, while pregnancy plans change the decision.

    October 5, 2026 · Elena Marsh, Health Writer

  14. A man sits on a window seat with a folded scarf

    SURMOUNT-3 Results: More Weight Loss After Diet

    After an average 6.9% loss through diet and exercise, selected trial participants lost another 18.4% on tirzepatide. Participants receiving an injection without tirzepatide gained 2.5% over the same 72 weeks.

    October 5, 2026 · Priya Raman, Health Writer

  15. A man stands in an open doorway with a glass of water

    Tirzepatide and Cholesterol: What the Numbers Mean

    Trials found larger changes in some blood fats than in the cholesterol linked to artery buildup. Here is what those percentages mean on a lab report.

    October 4, 2026 · Nadia Okonjo, Health Writer

  16. A man sits on a bench beside an allotment shed holding gardening gloves

    Gila Monster Weight Loss Drug: The Byetta Story

    Gila monster venom supplied the blueprint for exenatide, first marketed as Byetta. Semaglutide and tirzepatide are different, manufactured designs.

    October 3, 2026 · Nadia Okonjo, Health Writer

  17. A woman sits on a mat in a bright studio with a glass of water

    STEP 4 Trial Results: Regain After Wegovy Stops

    After 20 weeks on semaglutide, people who continued lost more weight. Those switched to placebo regained weight despite continued lifestyle support; who reached that switch shapes the answer.

    October 3, 2026 · Julian Reyes, Health Writer

  18. A man sits on a lounger in a quiet spa with a folded towel

    What Is an Estimand? Why Trials Report Two Numbers

    Two weight-loss numbers from one study can both be right. The difference is often whether the calculation includes treatment stops or assumes continued treatment.

    October 3, 2026 · Julian Reyes, Health Writer

  19. A man sits on a bench in a utility room with a folded towel

    SOUL Trial Results: Oral Semaglutide and the Heart

    Over about four years, fewer people taking a daily semaglutide tablet had a heart attack, stroke or cardiovascular death than people on placebo. Here is who was in the trial, what it counted, and what it can't tell you.

    October 2, 2026 · Priya Raman, Health Writer

  20. The front steps of a house with a ball of yarn

    SUSTAIN-6 Results: Ozempic's Heart and Eye Trial

    The 2016 trial that checked semaglutide's heart safety found fewer major heart events than placebo, and an eye-complication signal that still shapes the label today.

    October 2, 2026 · Elena Marsh, Health Writer

Page 6 of 17 · 331 articles